by Kazeem Olalekan It is that time of the year again when our Society, the Royal Pharmaceutical Society, is asking us to dig deep into our pockets and join or renew our membership. There is no obligation to do so but it is a nice thing to
Read more →
Updated advice on use of nicorandil as second-line treatment for stable angina – some ulcers may progress to complications unless treatment is stopped. More information here
Read more →
by Kazeem Olalekan In our next installment of the pre-registration project, Prabsimranjeet Rathaur describes his audit project on evaluating the use of patient controlled analgesia (PCA) on surgical and orthopaedic wards. …this may represent opportunity to review the current guideline with the hope of gaining consensus across all prescribers….I
Read more →
by Kazeem Olalekan We are always looking at ways to encourage different aspects of quality practice at bookapharmacist.com. To fulfill our audit dissemination agenda, we are encouraging pre-registrations pharmacists – past and present to discuss their audit/pre-reg project in a short time frame. Our first volunteer, Tomisin
Read more →
by Kazeem Olalekan Economists are a funny lot! They are obsessed with the two P’s of the economy: Performance & Productivity. Productivity is commonly defined as a ratio between output volume and the volume of input (1). As we know from our elementary physics – that
Read more →
by Kazeem Olalekan Today marks another landmark in the battle to combat and defeat the HIV. The theme for World Aids Day 2015 is “Getting to zero – ending AIDS by 2030” (link). This is an aspiration we all share especially with 37 million people living with
Read more →
by Kazeem Olalekan The latest Intensive Care National Audit and Research Centre (ICNARC) report showed the general intensive care unit (GICU) at Southampton General Hospital had the lowest number of deaths over a three-month period. Now that is something to be really proud of….Well done to the
Read more →
by Kazeem Olalekan MRPharmS The Medicines and Healthcare products Regulatory Agency has just issued a Class 4 Drug Safety Alert for Wockhardt UK Ltd – Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection. Alert details Drug alert number EL (14)A/09 in connection with the
Read more →
by Kazeem Olalekan When in March last year, Kazeem met Adel, it was bound to be another insightful interview and meeting of old mates. Adel featured in my first book: The Doctrine of Universal Truths. From one ‘wacky’ idea to the next, we stumbled along and then
Read more →
by Kazeem Olalekan MRPharmS Pharmacognosy is the branch of knowledge concerned with medicinal drugs obtained from plants or other natural sources. This has been critical to drug development and exemplified by the recent ward of the Nobel prize for medicines to the Chinese scientist Youyou Tu (a
Read more →
By Kazeem Olalekan With pressure on services across the NHS, it is time to really look at making better use of the third largest health professionals in the UK – The Pharmacists. Watch the video below produced by the Royal Pharmaceutical Society and your pharmacist will see
Read more →
by Kazeem Olalekan The following are some of the latest important updates from the newly April 2014 release of the BNF and BNFc: There are others: Do look at the BNFand BNFc websites
Read more →
by Kazeem Olalekan MRPharmS Whilst the controversy about statins heat up….my thoughts turn to staying alive. How does one stay alive in the face of controversy amongst experts? First, there is no dispute about whether or not statins save lives…they do. So if you are put on
Read more →
By Kazeem Olalekan MRPharmS As the long awaited release 2 of the Electronic Prescription Service rolls out of different GPs (almost certainly in April in Hampshire), we are running a series tagged EPS2 where we will highlight issues and gather your views. So join me in this
Read more →
by Kazeem Olalekan MRPharmS The construction of the COPD Pathway fills me with real excitement. I now, more or less know how to navigate my way through the myriad of services and service providers in the NHS: right from symptoms recognition right through to the end of
Read more →
